⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17410437 | 0.79 | TSHR (0.48) | — | |
| 1,2-Dichlorobenzene SCHEMBL2177256 | 0.76 | TSHR (0.71) | — | |
| SCHEMBL16421389 | 0.75 | CYP1A2 (0.35) | — | |
| SCHEMBL14273241 | 0.75 | ALDH1A1 (0.46) | — | |
| SCHEMBL14437309 | 0.72 | — | — | |
| SCHEMBL8349960 | 0.71 | CYP1A2 (0.45) | — | |
| SCHEMBL471457 | 0.69 | — | — | |
| SCHEMBL13300191 | 0.69 | TSHR (0.48) | — | |
| SCHEMBL14261346 | 0.69 | TSHR (0.48) | — | |
| 1,2-Dichlorobenzene SCHEMBL1155123 | 0.67 | TSHR (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3340983-B1 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | ACHILLION PHARMACEUTICALS INC (US) | 2023-10-04 | — | — | EP | disclosed |
| WO-2023279986-A1 | SIX-MEMBERED ARYL OR HETEROARYL AMIDES, AND COMPOSITION AND USE THEREOF | 贝达药业股份有限公司 | 2023-01-12 | — | — | WO | disclosed |
| EP-3611174-B1 | [1,2,4]TRIAZOLO[1,5-C]PYRIMIDINE DERIVATIVE AS A2A RECEPTOR INHIBITOR | MEDSHINE DISCOVERY INC (CN) | 2022-06-08 | — | — | EP | disclosed |
| EP-3340982-B1 | COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | ACHILLION PHARMACEUTICALS INC (US) | 2021-12-15 | — | — | EP | disclosed |
| WO-2021154966-A1 | COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERS | KAMARI PHARMA LTD. (IL) | 2021-08-05 | — | — | WO | disclosed |
| WO-2019143223-A9 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | 주식회사 엘지화학 | 2020-04-16 | — | — | WO | disclosed |
| EP-3611174-A1 | [1,2,4]TRIAZOLO[1,5-C]PYRIMIDINE DERIVATIVE AS A2A RECEPTOR INHIBITOR | Medshine Discovery Inc. (CN) | 2020-02-19 | — | — | EP | disclosed |
| WO-2019143223-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | 주식회사 엘지화학 | 2019-07-25 | — | — | WO | disclosed |
| US-20140163006-A1 | Pyrido-[2,3-D] Pyrimidines and Their Use as Kinase Inhibitors | FORMA THERAPEUTICS, INC. (US) | 2014-06-12 | — | — | US | disclosed |
| US-7571894-B2 | Organic electroluminescence element | FUJI PHOTO FILM CO., LTD. (JP) | 2009-08-11 | — | — | US | disclosed |
| EP-1670757-B1 | PYRROLE AND PYRAZOLE DERIVATIVES AS POTENTIATORS OF GLUTAMATE RECEPTORS | LILLY CO ELI (US) | 2009-05-06 | — | — | EP | disclosed |
| EP-1619177-B1 | ORGANIC ELECTROLUMINESCENCE ELEMENT | FUJIFILM CORP (JP) | 2008-02-27 | — | — | EP | disclosed |
| WO-2007092208-A1 | PHOTOTHERMOGRAPHIC MATERIALS INCORPORATING ARYLBORONIC ACIDS | CARESTREAM HEALTH, INC. (US) | 2007-08-16 | — | — | WO | disclosed |